124 related articles for article (PubMed ID: 38134863)
1. Targeted metabolomics reveals PFKFB3 as a key target for elemene-mediated inhibition of glycolysis in prostate cancer cells.
Dong XM; Chen L; Wu P; Cheng LH; Wang Y; Yang Y; Zhang Y; Tang WY; Xie T; Zhou JL
Phytomedicine; 2024 Jan; 123():155185. PubMed ID: 38134863
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.
Wang J; Li X; Xiao Z; Wang Y; Han Y; Li J; Zhu W; Leng Q; Wen Y; Wen X
FEBS Open Bio; 2019 Oct; 9(10):1798-1807. PubMed ID: 31410981
[TBL] [Abstract][Full Text] [Related]
3. TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis.
Zou L; Fang Y; He W
Mol Cell Probes; 2023 Jun; 69():101911. PubMed ID: 37003349
[TBL] [Abstract][Full Text] [Related]
4. Elemene induces cell apoptosis via inhibiting glutathione synthesis in lung adenocarcinoma.
Song GQ; Wu P; Dong XM; Cheng LH; Lu HQ; Lin YY; Tang WY; Xie T; Zhou JL
J Ethnopharmacol; 2023 Jul; 311():116409. PubMed ID: 37003401
[TBL] [Abstract][Full Text] [Related]
5. Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3.
Robinson AJ; Hopkins GL; Rastogi N; Hodges M; Doyle M; Davies S; Hole PS; Omidvar N; Darley RL; Tonks A
Cancer Res; 2020 Mar; 80(5):937-949. PubMed ID: 31862780
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma.
Li J; Zhang S; Liao D; Zhang Q; Chen C; Yang X; Jiang D; Pang J
BMC Cancer; 2022 Jan; 22(1):83. PubMed ID: 35057732
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of circ_0102273 inhibits the proliferation, metastasis and glycolysis of breast cancer through miR-1236-3p/PFKFB3 axis.
Yu H; Luo H; Liu X
Anticancer Drugs; 2022 Apr; 33(4):323-334. PubMed ID: 35266884
[TBL] [Abstract][Full Text] [Related]
8. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
[TBL] [Abstract][Full Text] [Related]
9. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT.
Liang Y; Li S; Zheng G; Zhang L
Acta Histochem; 2020 May; 122(4):151538. PubMed ID: 32183989
[TBL] [Abstract][Full Text] [Related]
10. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer.
Chowdhury N; Vhora I; Patel K; Doddapaneni R; Mondal A; Singh M
Pharm Res; 2017 Nov; 34(11):2371-2384. PubMed ID: 28875330
[TBL] [Abstract][Full Text] [Related]
11. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
12. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.
Li G; Xie B; Li X; Chen Y; Xu Y; Xu-Welliver M; Zou L
Oncol Rep; 2015 Mar; 33(3):1427-33. PubMed ID: 25607351
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
Li QQ; Wang G; Reed E; Huang L; Cuff CF
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):868-76. PubMed ID: 22545969
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Long J; Liu Z; Hui L
BMC Complement Altern Med; 2019 Jun; 19(1):133. PubMed ID: 31215421
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
[TBL] [Abstract][Full Text] [Related]
17. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
18. Marsdenia tenacissima (Roxb.) Moon injection exerts a potential anti-tumor effect in prostate cancer through inhibiting ErbB2-GSK3β-HIF1α signaling axis.
Chen X; Luo Z; Liu X; Li X; Li Q; Zhang W; Liu Y; Cheng Z; Yang X; Liu Y; Jin R; Zhu D; Wang F; Lu Q; Su Z; Guo H
J Ethnopharmacol; 2022 Sep; 295():115381. PubMed ID: 35595220
[TBL] [Abstract][Full Text] [Related]
19. β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.
Hu T; Gao Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010942
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
